1. Home
  2. UNCY vs VHC Comparison

UNCY vs VHC Comparison

Compare UNCY & VHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UNCY
  • VHC
  • Stock Information
  • Founded
  • UNCY 2016
  • VHC 2005
  • Country
  • UNCY United States
  • VHC United States
  • Employees
  • UNCY N/A
  • VHC N/A
  • Industry
  • UNCY Biotechnology: Pharmaceutical Preparations
  • VHC Multi-Sector Companies
  • Sector
  • UNCY Health Care
  • VHC Miscellaneous
  • Exchange
  • UNCY Nasdaq
  • VHC Nasdaq
  • Market Cap
  • UNCY 74.2M
  • VHC 70.7M
  • IPO Year
  • UNCY 2021
  • VHC 1999
  • Fundamental
  • Price
  • UNCY $4.42
  • VHC $22.00
  • Analyst Decision
  • UNCY Strong Buy
  • VHC
  • Analyst Count
  • UNCY 5
  • VHC 0
  • Target Price
  • UNCY $41.60
  • VHC N/A
  • AVG Volume (30 Days)
  • UNCY 459.6K
  • VHC 137.5K
  • Earning Date
  • UNCY 11-14-2025
  • VHC 11-10-2025
  • Dividend Yield
  • UNCY N/A
  • VHC N/A
  • EPS Growth
  • UNCY N/A
  • VHC N/A
  • EPS
  • UNCY N/A
  • VHC N/A
  • Revenue
  • UNCY N/A
  • VHC $50,000.00
  • Revenue This Year
  • UNCY N/A
  • VHC N/A
  • Revenue Next Year
  • UNCY $19,392.60
  • VHC N/A
  • P/E Ratio
  • UNCY N/A
  • VHC N/A
  • Revenue Growth
  • UNCY N/A
  • VHC 733.33
  • 52 Week Low
  • UNCY $3.71
  • VHC $3.68
  • 52 Week High
  • UNCY $11.00
  • VHC $29.00
  • Technical
  • Relative Strength Index (RSI)
  • UNCY 43.93
  • VHC 55.15
  • Support Level
  • UNCY $4.32
  • VHC $22.33
  • Resistance Level
  • UNCY $4.63
  • VHC $25.02
  • Average True Range (ATR)
  • UNCY 0.29
  • VHC 2.02
  • MACD
  • UNCY -0.08
  • VHC 0.09
  • Stochastic Oscillator
  • UNCY 12.61
  • VHC 42.86

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

About VHC VirnetX Holding Corp

VirnetX Holding Corp is engaged in the business of commercializing a portfolio of patents. It is an Internet security software and technology company with patented technology for secure communications. The company's software and technology solutions, including its Secure Domain Name Registry and Technology, VirnetX One, War Room, VirnetX Matrix, and GABRIEL Connection Technology, are designed to be device and location-independent, and enable a secure real-time communication environment for all types of enterprise applications, services and critical infrastructures.

Share on Social Networks: